Cargando…

Towards secondary prevention of early knee osteoarthritis

Osteoarthritis (OA) of the knee is the most common arthritic disease, yet a convincing drug treatment is not available. The current narrative review focuses on integration of scientific evidence and professional experience to illustrate which management approaches can be taken for prototypical indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoudian, Armaghan, Van Assche, Dieter, Herzog, Walter, Luyten, Frank P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109947/
https://www.ncbi.nlm.nih.gov/pubmed/30167325
http://dx.doi.org/10.1136/rmdopen-2017-000468
_version_ 1783350395965276160
author Mahmoudian, Armaghan
Van Assche, Dieter
Herzog, Walter
Luyten, Frank P
author_facet Mahmoudian, Armaghan
Van Assche, Dieter
Herzog, Walter
Luyten, Frank P
author_sort Mahmoudian, Armaghan
collection PubMed
description Osteoarthritis (OA) of the knee is the most common arthritic disease, yet a convincing drug treatment is not available. The current narrative review focuses on integration of scientific evidence and professional experience to illustrate which management approaches can be taken for prototypical individual patient profiles with early knee OA. Animal models suggest that: (1) OA can progress even in the presence of fully recovered movement kinetics, kinematics and muscle activation patterns; (2) muscle weakness is an independent risk factor for the onset and possibly the rate of progression of knee OA; (3) onset and progression of OA are not related to body weight but appear to depend on the percentage of body fat. From studies in the human model, one could postulate that risk factors associated with progression of knee OA include genetic traits, preceding traumatic events, obesity, intensity of pain at baseline, static and dynamic joint malalignment and reduced muscle strength. Taken this into account, an individual can be identified as early knee OA at high risk for disease progression. A holistic patient-tailored management including education, supportive medication, weight loss, exercise therapy (aerobic, strengthening and neuromuscular) and behavioural approaches to improve self-management of early knee OA is discussed in individual prototypic patients. Secondary prevention of early knee OA provides a window of opportunity to slow down or even reverse the disease process. Yet, as the sheer number of patients early in the OA disease process is probably large, a more structured approach is needed to provide appropriate care depending on the patient’s individual risk profile.
format Online
Article
Text
id pubmed-6109947
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-61099472018-08-30 Towards secondary prevention of early knee osteoarthritis Mahmoudian, Armaghan Van Assche, Dieter Herzog, Walter Luyten, Frank P RMD Open Osteoarthritis Osteoarthritis (OA) of the knee is the most common arthritic disease, yet a convincing drug treatment is not available. The current narrative review focuses on integration of scientific evidence and professional experience to illustrate which management approaches can be taken for prototypical individual patient profiles with early knee OA. Animal models suggest that: (1) OA can progress even in the presence of fully recovered movement kinetics, kinematics and muscle activation patterns; (2) muscle weakness is an independent risk factor for the onset and possibly the rate of progression of knee OA; (3) onset and progression of OA are not related to body weight but appear to depend on the percentage of body fat. From studies in the human model, one could postulate that risk factors associated with progression of knee OA include genetic traits, preceding traumatic events, obesity, intensity of pain at baseline, static and dynamic joint malalignment and reduced muscle strength. Taken this into account, an individual can be identified as early knee OA at high risk for disease progression. A holistic patient-tailored management including education, supportive medication, weight loss, exercise therapy (aerobic, strengthening and neuromuscular) and behavioural approaches to improve self-management of early knee OA is discussed in individual prototypic patients. Secondary prevention of early knee OA provides a window of opportunity to slow down or even reverse the disease process. Yet, as the sheer number of patients early in the OA disease process is probably large, a more structured approach is needed to provide appropriate care depending on the patient’s individual risk profile. BMJ Publishing Group 2018-08-13 /pmc/articles/PMC6109947/ /pubmed/30167325 http://dx.doi.org/10.1136/rmdopen-2017-000468 Text en © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0
spellingShingle Osteoarthritis
Mahmoudian, Armaghan
Van Assche, Dieter
Herzog, Walter
Luyten, Frank P
Towards secondary prevention of early knee osteoarthritis
title Towards secondary prevention of early knee osteoarthritis
title_full Towards secondary prevention of early knee osteoarthritis
title_fullStr Towards secondary prevention of early knee osteoarthritis
title_full_unstemmed Towards secondary prevention of early knee osteoarthritis
title_short Towards secondary prevention of early knee osteoarthritis
title_sort towards secondary prevention of early knee osteoarthritis
topic Osteoarthritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109947/
https://www.ncbi.nlm.nih.gov/pubmed/30167325
http://dx.doi.org/10.1136/rmdopen-2017-000468
work_keys_str_mv AT mahmoudianarmaghan towardssecondarypreventionofearlykneeosteoarthritis
AT vanasschedieter towardssecondarypreventionofearlykneeosteoarthritis
AT herzogwalter towardssecondarypreventionofearlykneeosteoarthritis
AT luytenfrankp towardssecondarypreventionofearlykneeosteoarthritis